"Ovarian Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Descriptor ID |
D010051
|
| MeSH Number(s) |
C04.588.322.455 C13.351.500.056.630.705 C13.351.937.418.685 C19.344.410 C19.391.630.705
|
| Concept/Terms |
Ovarian Neoplasms- Ovarian Neoplasms
- Neoplasm, Ovarian
- Ovarian Neoplasm
- Ovary Neoplasms
- Neoplasm, Ovary
- Neoplasms, Ovary
- Ovary Neoplasm
- Neoplasms, Ovarian
Ovary Cancer- Ovary Cancer
- Cancer, Ovary
- Cancers, Ovary
- Ovary Cancers
- Ovarian Cancer
- Cancer, Ovarian
- Cancers, Ovarian
- Ovarian Cancers
- Cancer of Ovary
- Cancer of the Ovary
|
Below are MeSH descriptors whose meaning is more general than "Ovarian Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Ovarian Neoplasms".
This graph shows the total number of publications written about "Ovarian Neoplasms" by people in this website by year, and whether "Ovarian Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 31 | 5 | 36 |
| 1995 | 22 | 10 | 32 |
| 1996 | 27 | 5 | 32 |
| 1997 | 23 | 7 | 30 |
| 1998 | 41 | 8 | 49 |
| 1999 | 36 | 12 | 48 |
| 2000 | 46 | 7 | 53 |
| 2001 | 48 | 5 | 53 |
| 2002 | 48 | 1 | 49 |
| 2003 | 64 | 17 | 81 |
| 2004 | 77 | 3 | 80 |
| 2005 | 79 | 8 | 87 |
| 2006 | 83 | 7 | 90 |
| 2007 | 100 | 11 | 111 |
| 2008 | 79 | 10 | 89 |
| 2009 | 63 | 13 | 76 |
| 2010 | 89 | 8 | 97 |
| 2011 | 82 | 15 | 97 |
| 2012 | 75 | 14 | 89 |
| 2013 | 83 | 7 | 90 |
| 2014 | 84 | 3 | 87 |
| 2015 | 84 | 11 | 95 |
| 2016 | 100 | 14 | 114 |
| 2017 | 69 | 10 | 79 |
| 2018 | 58 | 7 | 65 |
| 2019 | 85 | 7 | 92 |
| 2020 | 85 | 3 | 88 |
| 2021 | 88 | 3 | 91 |
| 2022 | 57 | 0 | 57 |
| 2023 | 61 | 1 | 62 |
| 2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.
-
Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024 Apr 01; 34(4):566-573.
-
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):469-477.
-
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunol Immunother. 2024 Mar 30; 73(5):80.
-
Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian Cancers. Discov Med. 2024 Mar; 36(182):632-645.
-
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. J Immunother Cancer. 2024 Feb 02; 12(2).
-
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024 Mar; 35(3):248-266.
-
Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy. JCO Oncol Pract. 2024 Apr; 20(4):517-524.
-
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. J Clin Oncol. 2024 Apr 10; 42(11):1301-1310.
-
Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024 Apr 01; 42(10):1102-1109.
-
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer. 2024 Mar; 130(5):861-868.